LEDERMAN SETH
Chief Executive Officer
LEDERMAN SETH has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Nov 12, 2026.
On the most recent filing, LEDERMAN SETH is listed as Chief Executive Officer at Tonix Pharmaceuticals Holding Corp. Inside the rolling window, LEDERMAN SETH reported 5 open-market purchases totaling $393K in TNXP and no open-market sales. The largest disclosed transaction in the window is a purchase of 15,000 TNXP shares on Mar 18, 2026, worth $223K.
Companies traded
Other insiders at TNXP
Insider Buying
$393K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has LEDERMAN SETH made?
LEDERMAN SETH has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does LEDERMAN SETH trade?
LEDERMAN SETH has filed SEC Form 4 disclosures for 1 company, including TNXP.
When was LEDERMAN SETH's most recent SEC Form 4 filing?
LEDERMAN SETH's most recent SEC Form 4 filing on Tracefour is dated Nov 12, 2026.
What is LEDERMAN SETH's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, LEDERMAN SETH is listed as Chief Executive Officer.
What is LEDERMAN SETH's total buy and sell value in the current window?
Inside the rolling retention window, LEDERMAN SETH bought $393K and sold $0 based on SEC Form 4 filings.
What was LEDERMAN SETH's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 15,000 TNXP shares on 2026-03-18, worth $223K, per SEC Form 4 filings.